Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol.
Matteo Airaldi, Yalin Zheng, Francesco Aiello...
https://pubmed.ncbi.nlm.nih.gov/37730252/Actively Recruiting
Led by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · Updated on 2025-10-02
135
Participants Needed
12
Research Sites
26 weeks
Total Duration
Researchers are evaluating a new method to assess the health of endothelial cells in donor corneal tissues before transplantation. This international observational study focuses on validating a technique that measures endothelial cell viability using Trypan Blue staining, aiming to improve predictions of long-term transplant outcomes. The study seeks to correlate these measurements with conventional assessments and actual patient outcomes after corneal transplant surgeries. The study involves preoperative analysis of donor corneal tissues using the V-Check method, which applies Trypan Blue dye to visualize and quantify dead or damaged endothelial cells. This evaluation occurs before keratoplasty procedures such as perforating keratoplasty, Descemet stripping automated endothelial keratoplasty, and Descemet membrane endothelial keratoplasty. The method is intended for use both by eye banks prior to shipment and by surgeons in the operating room. Participants receiving corneal transplants will be followed for 12 months post-surgery. Researchers will monitor endothelial cell loss, graft failure rates, and correlate preoperative Trypan Blue Positive Areas with declared endothelial cell density and mortality. Assessments include imaging analysis of donor tissues, clinical follow-ups, and measuring final endothelial cell density to understand how preoperative tissue viability impacts transplant success and complications.
CONDITIONS
The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study
M
Matteo Airaldi, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to the day of corneal transplantation
Participants undergo preoperative analysis of donor corneal tissue using Trypan Blue staining and image analysis to assess endothelial cell viability before keratoplasty.
1 visit (in-person) at the time of surgery
Duration - 12 months
Participants are monitored for endothelial cell loss, graft failure, and corneal tissue health up to 12 months after surgery.
Periodic follow-up visits for up to 12 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Matteo Airaldi, Yalin Zheng, Francesco Aiello...
https://pubmed.ncbi.nlm.nih.gov/37730252/Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Lead Sponsor